Tecan Group AG (TCHBF)
OTHER OTC:TCHBF
TCHBF Stock Chart & Stats
$170.85
-$6.96(-3.24%)
At close: 4:00 PM EST
$170.85
-$6.96(-3.24%)
Day’s Range― - ―
52-Week Range$136.95 - $225.00
Previous CloseN/A
Volume4.00
Average Volume (3M)2.00
Market Cap
$2.19B
Enterprise Value$1.75B
Total Cash (Recent Filing)$311.37M
Total Debt (Recent Filing)$218.32M
Price to Earnings (P/E)―
Beta0.87
Next Earnings
Aug 19, 2026EPS Estimate
3.67Next Dividend Ex-DateN/A
Dividend Yield2.3%
Share Statistics
EPS (TTM)5.40
Shares Outstanding12,825,883
10 Day Avg. Volume7
30 Day Avg. Volume2
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)1.41
Price to Sales (P/S)1.84
P/FCF Ratio15.85
Enterprise Value/Market Cap0.80
Enterprise Value/Revenue1.98
Enterprise Value/Gross Profit5.63
Enterprise Value/Ebitda25.03
Forecast
1Y Price Target
$205.27Price Target Upside20.15% Upside
Rating ConsensusHold
Number of Analyst Covering5
EPS Forecast (FY)7.55
Revenue Forecast (FY)$1.10B
Bulls Say, Bears Say
Bulls Say
Conservative Leverage / Strong Balance SheetLow debt-to-equity provides durable financial flexibility, enabling the company to fund R&D, product launches, and buybacks without forcing asset sales. This conservatism supports multi-year investments and shields capital structure through cyclical weakness in labs and diagnostics markets.
Consistent Operating Cash GenerationPositive operating cash flow across years demonstrates the business converts sales into cash even when earnings falter, supporting service networks, consumable replenishment and OEM commitments. This cash resiliency underpins multi-year funding for product rollout and working capital needs.
Healthy Order Pipeline And Product InnovationA book-to-bill above 1 signals sustainable demand momentum and backlog that supports revenue recovery. Coupled with new workstations and dispensers, this indicates durable demand for instruments that drive follow-on consumables, services and OEM opportunities over several quarters.
Bears Say
Multi-year Revenue Decline And 2025 Net LossSustained top-line contraction and a swing to a significant net loss weaken earnings quality and reduce retained capital for reinvestment. If structural demand issues persist, margins and ROE may remain impaired, limiting long-term capacity to restore historic profitability levels.
Partnering/OEM Business Weakness And China SlowdownDeclines in the Partnering segment and China sales reduce a high-leverage channel for instruments and recurring consumables. Given OEM relationships and China importance, prolonged softness erodes installed base growth and recurring revenue, pressuring medium-term cash and service income.
Margin Sensitivity To Tariffs, FX And Non-operating ItemsExposure to tariffs and currency moves creates ongoing margin volatility and can convert operating resilience into reported losses. Combined with one-off or non-operating hits that drove the 2025 net loss, this structural sensitivity raises uncertainty around sustaining target EBITDA margins.
Tecan Group AG News
TCHBF FAQ
What was Tecan Group AG’s price range in the past 12 months?
Tecan Group AG lowest stock price was $136.95 and its highest was $225.00 in the past 12 months.
What is Tecan Group AG’s market cap?
Tecan Group AG’s market cap is $2.19B.
When is Tecan Group AG’s upcoming earnings report date?
Tecan Group AG’s upcoming earnings report date is Aug 19, 2026 which is in 129 days.
How were Tecan Group AG’s earnings last quarter?
Tecan Group AG released its earnings results on Mar 16, 2026. The company reported $5.398 earnings per share for the quarter, beating the consensus estimate of $4.295 by $1.102.
Is Tecan Group AG overvalued?
According to Wall Street analysts Tecan Group AG’s price is currently Undervalued.
Does Tecan Group AG pay dividends?
Tecan Group AG pays a Annually dividend of $3.747 which represents an annual dividend yield of 2.3%. See more information on Tecan Group AG dividends here
What is Tecan Group AG’s EPS estimate?
Tecan Group AG’s EPS estimate is 3.67.
How many shares outstanding does Tecan Group AG have?
Tecan Group AG has 12,825,883 shares outstanding.
What happened to Tecan Group AG’s price movement after its last earnings report?
Tecan Group AG reported an EPS of $5.398 in its last earnings report, beating expectations of $4.295. Following the earnings report the stock price went down -3.018%.
Which hedge fund is a major shareholder of Tecan Group AG?
Currently, no hedge funds are holding shares in TCHBF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Tecan Group AG
Tecan Group AG provides laboratory instruments and solutions for pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and microbodies, and software; Tecan Laberwax, an automation solution; Resolvex, a smart sample preparation solution for use in genomics, synthetic biology, drug discovery, analytical chemistry, cell biology, protein science, applied markets, and ELISA solutions. It also develops and manufactures laboratory instrument manufacturers with essential components comprising precision pumps, valves, robotic arms, and developer software for life science research, diagnostics, and various other industries; Synergence, platform-based automation solution; and Freedom EVO and Fluent instruments. The company operates in Switzerland and Other European countries, North America, Asia, and internationally. Tecan Group AG was founded in 1980 and is headquartered in Männedorf, Switzerland.
TCHBF Company Deck
TCHBF Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture. While Tecan reported strong order entry and growth in the Life Sciences business, challenges in China, a decline in the Partnering Business, and external factors such as tariffs and currency impacts posed significant challenges. The company's strategic initiatives in cost reduction and innovation are positive, but the current market environment remains difficult.View all TCHBF earnings summariesTCHBF Stock 12 Month Forecast
Average Price Target
$205.27
▲(20.15% Upside)
Technical Analysis
Medacta Group SA
―
Siegfried Holding AG
―
Ypsomed Holding AG
―
SKAN Group AG
―
Medartis Holding AG
―
Ownership Overview
―
Insiders
6.62% Mutual Funds
<0.01% Other Institutional Investors
83.34% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---